返回
J
Jakob Passweg
university hospital basel
100H指数
1.0K论文数
4.2W被引数
收录论文 211
发表时间
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation更正:费城染色体阳性急性淋巴细胞白血病合并附加细胞遗传学异常的移植结局:欧洲血液与骨髓移植学会急性白血病工作组的研究
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation欧洲血液与骨髓移植学会急性白血病工作组关于调节方案对<40岁处于完全缓解期并接受HCT治疗的AML患者结局的影响(移植调节强度评分为3.5-4.0)的研究
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)544例t(6;9)/DEK::NUP214急性髓系白血病患者行异基因干细胞移植的结局:欧洲血液和骨髓移植组急性白血病工作组(ALWP)和儿科疾病工作组(PDWP)的代表性研究
IGLV3-21R110-directed bispecific antibodies activate T cells and promote killing in ahigh-risk subset of chronic lymphocytic leukemiaFischer, C.; Chen, S.S.; Nimmerfroh, J.; Eugster, A.; Stucheli, S.; Schultheiss, C.; Widmer, C.; Heim, D.; Kasenda, B.; Passweg, J.; et al. IGLV3-21(R110)靶向双特异性抗体可激活T细胞并促进在慢性淋巴细胞白血病高风险亚群中的杀伤作用。Haematologica 2025. [Google Scholar] [CrossRef]
Haematologica
IF7.9
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on ‘real world’ experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm一项由EBMT慢性恶性疾病工作组代表进行的关于异基因造血细胞移植治疗骨髓纤维化的欧洲调查:聚焦于JAK抑制剂的“真实世界”经验、脾肿大管理以及移植算法中的新型药物
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Partyhaploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide的并发症——EBMT移植并发症工作组发起的一项前瞻性研究
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT移植后环磷酰胺与抗胸腺细胞球蛋白在合并心血管并发症、接受无关供者异基因造血细胞移植治疗首次完全缓解期急性髓系白血病患者中的比较:一项来自EBMT ALWP的回顾性配对分析

